Topics

Integrin Alpha 4 CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4 Pipeline Review, H1 2019 [Report Updated: 29032019] Prices from USD $3500

21:32 EDT 30 May 2019 | BioPortfolio Report Blog

Integrin Alpha 4 CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4 Pipeline Review, H1 2019


Summary


Integrin Alpha 4 CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4 Integrin Alpha 4 is a protein encoded by ITGA4. Integrins alpha4 VLA4 subunit associates with a beta 1 or beta7 subunit to form an integrin that plays a role in cell motility and migration. This integrin is a therapeutic target for the treatment of multiple sclerosis, Crohn's disease and inflammatory bowel disease. They are receptors for fibronectin. They recognize one or more domains within the alternatively spliced CS1 and CS5 regions of fibronectin. They are also receptors for VCAM1.


Integrin Alpha 4 CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4 pipeline Target constitutes close to 14 molecules. The molecules developed by companies in PreRegistration, Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 1, 4, 1, 3 and 4 respectively.


Report covers products from therapy areas Gastrointestinal, Central Nervous System, Immunology, Infectious Disease, Oncology, Ophthalmology, Cardiovascular, Genetic Disorders, Respiratory and Undisclosed which include indications Inflammatory Bowel Disease, Ulcerative Colitis, Graft Versus Host Disease GVHD, Acute Myelocytic Leukemia AML, Acute Myeloblastic Leukemia, Age Related Macular Degeneration, Asthma, Autoimmune Disorders, Crohn's Disease Regional Enteritis, Duchenne Muscular Dystrophy, Epilepsy, Genital Warts Condylomata Acuminata, Human Immunodeficiency Virus HIV Infections AIDS, Keratoconjunctivitis Sicca Dry Eye, Multiple Sclerosis, Paraneoplastic Syndrome, Relapsing Remitting Multiple Sclerosis RRMS, Secondary Progressive Multiple Sclerosis SPMS, Unspecified and Ventricular Septal Defect.


The latest report Integrin Alpha 4 Pipeline Review, H1 2019, outlays comprehensive information on the Integrin Alpha 4 CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action MoA, route of administration RoA and molecule type. It also reviews key players involved in Integrin Alpha 4 CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4 targeted therapeutics development with respective active and dormant or discontinued projects.


The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industryspecific third party sources.


Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.


Scope


The report provides a snapshot of the global therapeutic landscape for Integrin Alpha 4 CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4

The report reviews Integrin Alpha 4 CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4 targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industryspecific sources

The report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, RD brief, licensing and collaboration details other developmental activities

The report reviews key players involved in Integrin Alpha 4 CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4 targeted therapeutics and enlists all their major and minor projects

The report assesses Integrin Alpha 4 CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4 targeted therapeutics based on mechanism of action MoA, route of administration RoA and molecule type

The report summarizes all the dormant and discontinued pipeline projects

The report reviews latest news and deals related to Integrin Alpha 4 CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4 targeted therapeutics


Reasons to buy


Gain strategically significant competitor information, analysis, and insights to formulate effective RD strategies

Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage

Identify and understand the targeted therapy areas and indications for Integrin Alpha 4 CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4

Identify the use of drugs for target identification and drug repurposing

Identify potential new clients or partners in the target demographic

Develop strategic initiatives by understanding the focus areas of leading companies

Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Integrin Alpha 4 CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4 development landscape

Develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Original Article: Integrin Alpha 4 CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4 Pipeline Review, H1 2019 [Report Updated: 29032019] Prices from USD $3500

NEXT ARTICLE

More From BioPortfolio on "Integrin Alpha 4 CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4 Pipeline Review, H1 2019 [Report Updated: 29032019] Prices from USD $3500"

Quick Search

Relevant Topic

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...